122 related articles for article (PubMed ID: 15828235)
21. PPARs and the kidney in metabolic syndrome.
Ruan X; Zheng F; Guan Y
Am J Physiol Renal Physiol; 2008 May; 294(5):F1032-47. PubMed ID: 18234957
[TBL] [Abstract][Full Text] [Related]
22. Expression patterns of the chicken peroxisome proliferator-activated receptors (PPARs) during the development of the digestive organs.
Hojo M; Takada I; Kimura W; Fukuda K; Yasugi S
Gene Expr Patterns; 2006 Jan; 6(2):171-9. PubMed ID: 16325478
[TBL] [Abstract][Full Text] [Related]
23. [Autoimmune disease].
Yoshikawa T; Kawahito Y
Nihon Rinsho; 2005 Apr; 63(4):687-90. PubMed ID: 15828238
[TBL] [Abstract][Full Text] [Related]
24. [PPARgamma as a new therapeutic target in inflammatory diseases].
Naito Y; Yoshikawa T
Nihon Rinsho; 2010 Feb; 68(2):341-9. PubMed ID: 20158107
[TBL] [Abstract][Full Text] [Related]
25. Peroxisome proliferator-activated receptors gamma reverses hepatic nutritional fibrosis in mice and suppresses activation of hepatic stellate cells in vitro.
Yu J; Zhang S; Chu ES; Go MY; Lau RH; Zhao J; Wu CW; Tong L; Zhao J; Poon TC; Sung JJ
Int J Biochem Cell Biol; 2010 Jun; 42(6):948-57. PubMed ID: 20156580
[TBL] [Abstract][Full Text] [Related]
26. [PPAR and NASH].
Tanaka N; Aoyama T
Nihon Rinsho; 2006 Jun; 64(6):1089-94. PubMed ID: 16768114
[TBL] [Abstract][Full Text] [Related]
27. The role of PPARs in inflammation and immunity.
Clark RB
J Leukoc Biol; 2002 Mar; 71(3):388-400. PubMed ID: 11867676
[TBL] [Abstract][Full Text] [Related]
28. Emerging roles of peroxisome proliferator-activated receptor-beta/delta in inflammation.
Bishop-Bailey D; Bystrom J
Pharmacol Ther; 2009 Nov; 124(2):141-50. PubMed ID: 19615407
[TBL] [Abstract][Full Text] [Related]
29. Peroxisome proliferator-activated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice.
Osawa E; Nakajima A; Wada K; Ishimine S; Fujisawa N; Kawamori T; Matsuhashi N; Kadowaki T; Ochiai M; Sekihara H; Nakagama H
Gastroenterology; 2003 Feb; 124(2):361-7. PubMed ID: 12557142
[TBL] [Abstract][Full Text] [Related]
30. [Nuclear Receptor PPARs and magnesium].
Fujii H
Clin Calcium; 2005 Nov; 15(11):52-64. PubMed ID: 16272614
[TBL] [Abstract][Full Text] [Related]
31. Activation of mouse and human peroxisome proliferator-activated receptors (PPARs) by phthalate monoesters.
Bility MT; Thompson JT; McKee RH; David RM; Butala JH; Vanden Heuvel JP; Peters JM
Toxicol Sci; 2004 Nov; 82(1):170-82. PubMed ID: 15310864
[TBL] [Abstract][Full Text] [Related]
32. [PPARgamma agonists for the diseases of gastrointestinal tract and liver].
Shimada T; Hiraishi H
Nihon Rinsho; 2010 Feb; 68(2):312-6. PubMed ID: 20158102
[TBL] [Abstract][Full Text] [Related]
33. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy.
Rubin GL; Zhao Y; Kalus AM; Simpson ER
Cancer Res; 2000 Mar; 60(6):1604-8. PubMed ID: 10749129
[TBL] [Abstract][Full Text] [Related]
34. Expression of peroxisome proliferator-activated receptor gamma and the growth inhibitory effect of its synthetic ligands in human salivary gland cancer cell lines.
Begum NM; Nakashiro K; Kawamata H; Uchida D; Shintani S; Ikawa Y; Sato M; Hamakawa H
Int J Oncol; 2002 Mar; 20(3):599-605. PubMed ID: 11836575
[TBL] [Abstract][Full Text] [Related]
35. Peroxisome proliferator-activated receptor gamma as a novel therapeutic target in asthma.
Park SJ; Lee YC
J Asthma; 2008; 45(1):1-8. PubMed ID: 18259989
[TBL] [Abstract][Full Text] [Related]
36. Expression of PPARgamma and beta/delta in human primary osteoblastic cells: influence of polyunsaturated fatty acids.
Maurin AC; Chavassieux PM; Meunier PJ
Calcif Tissue Int; 2005 May; 76(5):385-92. PubMed ID: 15868283
[TBL] [Abstract][Full Text] [Related]
37. Role of peroxisome proliferators-activated receptors in the pathogenesis and treatment of nonalcoholic fatty liver disease.
Kallwitz ER; McLachlan A; Cotler SJ
World J Gastroenterol; 2008 Jan; 14(1):22-8. PubMed ID: 18176957
[TBL] [Abstract][Full Text] [Related]
38. Expression and potential role of peroxisome proliferator-activated receptor gamma in the placenta of diabetic pregnancy.
Suwaki N; Masuyama H; Masumoto A; Takamoto N; Hiramatsu Y
Placenta; 2007 Apr; 28(4):315-23. PubMed ID: 16753211
[TBL] [Abstract][Full Text] [Related]
39. PPAR ligands: are they potential agents for cardiovascular disorders?
Balakumar P; Rose M; Singh M
Pharmacology; 2007; 80(1):1-10. PubMed ID: 17496434
[TBL] [Abstract][Full Text] [Related]
40. PPARs in the brain.
Heneka MT; Landreth GE
Biochim Biophys Acta; 2007 Aug; 1771(8):1031-45. PubMed ID: 17569578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
